These evidences were associated with increased survival of breast cancer patients who had a specific pattern of three lncRNAs, including reduced levels of PTPRG-AS1 (Zhao et al., 2014; Iranpour et al., 2016) (Table 1). This evidence concerns the gene PTPRG and breast carcinoma.